How did Intuitive Surgical's revenue perform in the second quarter of 2021 compared to the prior year?

Total revenue for the second quarter of 2021 increased significantly by 72% to $1.46 billion, compared to $0.85 billion for the second quarter of 2020. This growth was driven by higher systems revenue (up 68%), instruments and accessories revenue (up 73%), and service revenue (up 75%).

What is the company's outlook regarding the impact of the COVID-19 pandemic?

The company acknowledges that while procedure volumes have recovered significantly, the COVID-19 pandemic continues to present uncertainties. Regional variations in vaccination rates and COVID-19 case surges may still impact procedure volumes and hospital spending. However, the company's strong performance in Q2 2021 suggests a robust recovery and adaptability.

What is the company's liquidity position as of June 30, 2021?

Intuitive Surgical maintained a strong liquidity position, with $7.73 billion in cash, cash equivalents, and investments as of June 30, 2021. This represents an increase from $6.87 billion at the end of 2020, primarily due to cash provided by operations.

What are the key drivers for the significant increase in operating income?

The substantial increase in operating income (534% year-over-year) is primarily attributable to the strong revenue growth, improved gross profit margins, and a more efficient operating expense structure relative to revenue, especially as the company recovers from pandemic-related impacts experienced in the prior year.

ISRG 10-Q Quarterly Report Q2 FY2021 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) reported a robust financial performance for the quarter and six months ended June 30, 2021. Total revenue surged by 72% year-over-year to $1.46 billion for the second quarter, driven by strong growth across all key segments: systems, instruments and accessories, and services. This recovery reflects a significant rebound from the COVID-19 pandemic's impact in the prior year. Profitability also saw a substantial improvement, with income from operations increasing dramatically and gross profit margin expanding to 70%. The company's strategic focus on innovation and expanding the reach of minimally invasive care, coupled with a strong recovery in da Vinci procedure volumes globally, positions ISRG for continued growth. The company maintains a healthy cash position and continues to invest in research and development for future innovation.

Financial Highlights

47 data points

Beta

Revenue

$1.46B

0.7% Gross Margin

Net Income

$517.20M

0.4% Net Margin

EPS (Diluted)

$1.42

Total Assets

$12.30B

Cash & Equivalents

$1.62B

Free Cash Flow

$542.70M

Financial Statements

Beta

Revenue	$1.46B
Cost of Revenue	$440.30M
Gross Profit	$1.02B
R&D Expenses	$162.30M
SG&A Expenses	$350.20M
Operating Expenses	$512.50M
Operating Income	$511.20M
Net Income	$517.20M
EPS (Basic)	$1.45
EPS (Diluted)	$1.42
Shares Outstanding (Basic)	355.70M
Shares Outstanding (Diluted)	364.90M

Key Highlights

1Total revenue for Q2 2021 increased 72% year-over-year to $1.46 billion, driven by strong performance across all revenue streams.
2Gross profit margin improved significantly to 70% in Q2 2021, up from 59% in Q2 2020, indicating enhanced operational efficiency and pricing power.
3Da Vinci procedures performed increased by 68% year-over-year in Q2 2021, signaling a strong recovery and growing adoption of robotic-assisted surgery.
4Systems revenue grew 68% and instrument & accessory revenue grew 73% year-over-year in Q2 2021, reflecting increased system placements and procedure volume.
5The company shipped 328 da Vinci Surgical Systems in Q2 2021, an 84% increase from Q2 2020, demonstrating strong demand for its core products.
6Income from operations saw a substantial increase of 534% year-over-year, reaching $511 million in Q2 2021, highlighting improved profitability.
7Intuitive Surgical ended the quarter with a strong liquidity position, reporting $7.73 billion in cash, cash equivalents, and investments.

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2021

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions